MYLAN 217 250 (Tolazamide 250 mg)
This pill with imprint "MYLAN 217 250" is White, Round and has been identified as Tolazamide 250 mg. It is manufactured by Mylan Pharmaceuticals Inc..
Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 217 250
- Strength:
- 250 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0217
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Note: Inactive ingredients may vary.
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0556 | Amerisource Health Services |
More about tolazamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: sulfonylureas
Consumer resources
Other brands: Tolinase
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
